Message From Executive Director

Dear Friends, Positive things are happening! It is time that EVERYONE recognizes the fact that schizophrenia-related disorders/illnesses are BRAIN based and are treatable.  SARDAA is launching a BRAIN Campaign to change erroneous perceptions and inform the medical, legislative and general public regarding schizophrenia-related brain disorders. Emmett Biffle, a SARDAA Board member, educated her University ofRead More

[Continue reading…]

Marijuana Use Impairs Verbal Memory

Individuals with long-term exposure to marijuana may experience significant impairment of verbal memory by the time they reach middle age, warn researchers, who found that other aspects of cognitive function were unaffected. Investigators, led by Reto Auer, MD, of the Department of Ambulatory Care and Community Medicine, University of Lausanne, Switzerland, found that for eachRead More

[Continue reading…]

Today’s Research on Medicines for Children Offers Hope for Tomorrow

Only 25 years ago, it was rare to find drug labels with dispensing information specific to children. That’s because pharmaceutical companies rarely, if ever, conducted the research necessary to develop such instructions. As a result, health care providers often gave children smaller doses of adult medicines, without evidence of how exactly the children would react.Read More

[Continue reading…]

SAMHSA’s 2015 Barometer tracks the behavioral health of America

The Substance Abuse and Mental Health Services Administration’s (SAMHSA) most recent National Behavioral Health Barometer report (Barometer) highlights many important trends in Americans’ behavioral health throughout the nation. The 2015 Barometer findings cover key behavioral healthcare issues affecting American communities including the prevalence rates of youth and adult substance use, serious mental illness, suicidal thoughts,Read More

[Continue reading…]

Tax-advantaged Savings program for qualified disability expenses

The Stephen Beck, Jr., Achieving a Better Life Experience Act  (ABLE Act) was enacted on December 19, 2014, as part of The Tax Increase Prevention Act of 2014 (P.L. 113–295). Generally, the ABLE Act permits a state to establish and maintain a new type of tax-advantaged savings program (under Section 529A of the Internal RevenueRead More

[Continue reading…]

Need a dose of inspiration?

Sardaa health storylines2

Is there something that you have been mustering up the courage to do to better yourself? Build your hope and confidence by getting your daily dose of inspiration with Healthy Doses in your SARDAA Health Storylines app. Whether you are looking for optimism, love, gratitude, mindfulness, or something to make you smile; Healthy DosesRead More

[Continue reading…]

Metformin May Normalize Antipsychotic-Induced Lipid Imbalance in People With Schizophrenia

Metformin

Patients with schizophrenia who take antipsychotics commonly experience serious adverse metabolic effects including dyslipidemia—a condition characterized by abnormally high levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), or triglycerides, as well as abnormally low levels of high-density lipoprotein cholesterol (HDL-C). A study published in Molecular Psychiatry now suggests that the type 2 diabetes medicationRead More

[Continue reading…]

Experimental Combination Surprises with Anti-HIV Effectiveness

A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected. The potency of the combination treatment, tested so far in mice, suggests that it would be possible to rid the body of HIV for months, reducing the frequency with which patientsRead More

[Continue reading…]

Genome-Wide Study Yields Markers of Lithium Response

An international consortium of scientists has identified a stretch of chromosome that is associated with responsiveness to the mood-stabilizing medication lithium among patients with bipolar disorder. While the finding won’t have an immediate clinical application, it is a groundbreaking demonstration of the potential for identifying genetic information that can be used to inform personalized treatmentRead More

[Continue reading…]

Schizophrenia’s strongest known genetic risk deconstructed

Suspect gene may trigger runaway synaptic pruning during adolescence – NIH-funded study Versions of a gene linked to schizophrenia may trigger runaway pruning of the teenage brain’s still-maturing communications infrastructure, NIH-funded researchers have discovered.  People with the illness show fewer such connections between neurons, or synapses.  The gene switched on more in people with the suspectRead More

[Continue reading…]